Sperm DNA methylation dynamics after chemotherapy: a longitudinal study of a patient with testicular germ cell tumor treatment.
bisulfite sequencing
chemotherapy
epigenome
methylation
sperm
testis cancer
Journal
Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129
Informations de publication
Date de publication:
24 Jun 2023
24 Jun 2023
Historique:
revised:
26
05
2023
received:
10
01
2023
accepted:
19
06
2023
pubmed:
24
6
2023
medline:
24
6
2023
entrez:
24
6
2023
Statut:
aheadofprint
Résumé
An important issue for young men affected by testicular germ cell tumor (TGCT) is how TGCT and its treatment will affect, transiently or permanently, their future reproductive health. Previous studies have reported that xenobiotics can induce changes on human sperm epigenome and have the potential to promote epigenetic alterations in the offspring. Here, we report the first longitudinal DNA methylation profiling of frozen sperm from a TGCT patient before and up to 2 years after a bleomycin, etoposide, and cisplatin (BEP) chemotherapy. A TGCT was diagnosed in a 30-year-old patient. A cryopreservation of spermatozoa was proposed before adjuvant BEP treatment. Semen samples were collected before and after chemotherapy at 6, 9, 12, and 24 months. The DNA methylation status was determined by RRBS to detect DNA differentially methylated regions (DMRs). The analysis revealed that among the 74 DMRs showing modified methylation status 6 months after therapy, 17 remained altered 24 months after treatment. We next associated DMRs with differentially methylated genes (DMGs), which were subsequently intersected with loci known to be important or expressed during early development. The consequences of the cancer treatment on the sperm epigenome during the recovery periods are topical issues of increasing significance as epigenetic modifications to the paternal genome may have deleterious effects on the offspring. The altered methylated status of these DMGs important for early development might modify their expression pattern and thus affect their function during key stages of embryogenesis, potentially leading to developmental disorders or miscarriages.
Sections du résumé
BACKGROUND
BACKGROUND
An important issue for young men affected by testicular germ cell tumor (TGCT) is how TGCT and its treatment will affect, transiently or permanently, their future reproductive health. Previous studies have reported that xenobiotics can induce changes on human sperm epigenome and have the potential to promote epigenetic alterations in the offspring.
OBJECTIVES
OBJECTIVE
Here, we report the first longitudinal DNA methylation profiling of frozen sperm from a TGCT patient before and up to 2 years after a bleomycin, etoposide, and cisplatin (BEP) chemotherapy.
MATERIALS AND METHODS
METHODS
A TGCT was diagnosed in a 30-year-old patient. A cryopreservation of spermatozoa was proposed before adjuvant BEP treatment. Semen samples were collected before and after chemotherapy at 6, 9, 12, and 24 months. The DNA methylation status was determined by RRBS to detect DNA differentially methylated regions (DMRs).
RESULTS
RESULTS
The analysis revealed that among the 74 DMRs showing modified methylation status 6 months after therapy, 17 remained altered 24 months after treatment. We next associated DMRs with differentially methylated genes (DMGs), which were subsequently intersected with loci known to be important or expressed during early development.
DISCUSSION AND CONCLUSION
CONCLUSIONS
The consequences of the cancer treatment on the sperm epigenome during the recovery periods are topical issues of increasing significance as epigenetic modifications to the paternal genome may have deleterious effects on the offspring. The altered methylated status of these DMGs important for early development might modify their expression pattern and thus affect their function during key stages of embryogenesis, potentially leading to developmental disorders or miscarriages.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 The Authors. Andrology published by Wiley Periodicals LLC on behalf of American Society of Andrology and European Academy of Andrology.
Références
Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer. 2009;45(6):931-991.
Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F. Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol. 2011;60(1):1-15.
Parkin DM, Ferlay J, Curado MP, et al. Fifty years of cancer incidence: cI5 I-IX. Int J Cancer. 2010;127(12):2918-2927.
Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Møller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer. 2006;118(12):3099-3111.
Znaor A, Lortet-Tieulent J, Jemal A, Bray F. International variations and trends in testicular cancer incidence and mortality. Eur Urol. 2014;65(6):1095-1106.
Nigam M, Aschebrook-Kilfoy B, Shikanov S, Eggener S. Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World J Urol. 2015;33(5):623-631.
Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW. Testicular cancer: marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer. 2008;122(3):639-642.
Huyghe E, Plante P, Thonneau PF. Testicular cancer variations in time and space in Europe. Eur Urol. 2007;51(3):621-628.
Auger J, Sermondade N, Eustache F. Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations. Basic Clin Androl. 2016;26:3.
Bujan L, Walschaerts M, Moinard N, et al. Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network. Fertil Steril. 2013;100(3):673-680.
Jeruss J, Woodruff T. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902-911.
Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500-2510.
Martinez G, Walschaerts M, Le Mitouard M, et al. Impact of Hodgkin or non-Hodgkin lymphoma and their treatments on sperm aneuploidy: a prospective study by the French CECOS network. Fertil Steril. 2017;107:341-350.
Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(18):2917-2931.
Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001;7(4):394-403.
O'Flaherty C, Hales BF, Chan P, Robaire B. Impact of chemotherapeutics and advanced testicular cancer or Hodgkin lymphoma on sperm deoxyribonucleic acid integrity. Fertil Steril. 2010;94(4):1374-1379.
Smit M, van Casteren NJ, Wildhagen MF, Romijn JC, Dohle GR. Sperm DNA integrity in cancer patients before and after cytotoxic treatment. Hum Reprod. 2010;25(8):1877-1883.
Ståhl O, Eberhard J, Cavallin-Ståhl E, et al. Sperm DNA integrity in cancer patients: the effect of disease and treatment. Int J Androl. 2009;32(6):695-703.
Shnorhavorian M, Schwartz SM, Stansfeld B, Sadler-Riggleman I, Beck D, Skinner MK. Differential DNA methylation regions in adult human sperm following adolescent chemotherapy: potential for epigenetic inheritance. PLoS One. 2017;12(2):e0170085.
Berthaut I, Montjean D, Dessolle L, et al. Effect of temozolomide on male gametes: an epigenetic risk to the offspring? J Assist Reprod Genet. 2013;30(6):827-833.
Rives N, Walschaerts M, Setif V, et al. Sperm aneuploidy after testicular cancer treatment: data from a prospective multicenter study performed within the French Centre d’Étude et de Conservation des Oeufs et du Sperme network. Fertil Steril. 2017;107(3):580-588.
Martos SN, Tang WY, Wang Z. Elusive inheritance: transgenerational effects and epigenetic inheritance in human environmental disease. Prog Biophys Mol Biol. 2015;118(1-2):44-54.
Hanson MA, Skinner MK. Developmental origins of epigenetic transgenerational inheritance. Environ Epigenet. 2016;2(1):dvw002.
Nilsson EE, Sadler-Riggleman I, Skinner MK. Environmentally induced epigenetic transgenerational inheritance of disease. Environ Epigenet. 2018;4(2):dvy016.
Meissner A, Gnirke A, Bell GW, Ramsahoye B, Lander ES, Jaenisch R. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. 2005;33(18):5868-5877.
Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27(11):1571-1572.
Hebestreit K, Dugas M, Klein HU. Detection of significantly differentially methylated regions in targeted bisulfite sequencing data. Bioinformatics. 2013;29(13):1647-1653.
Eckhardt F, Lewin J, Cortese R, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet. 2006;38(12):1378-1385.
Hansen KD, Langmead B, Irizarry RA. BSmooth: from whole genome bisulfite sequencing reads to differentially methylated regions. Genome Biol. 2012;13(10):R83.
Jaffe AE, Murakami P, Lee H, et al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol. 2012;41(1):200-209.
Watt F, Molloy PL. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev. 1988;2(9):1136-1143.
Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3(1):1-25.
Yates A, Akanni W, Amode MR, et al. Ensembl 2016. Nucleic Acids Res. 2016;44(D1):D710-D716.
Brown GR, Hem V, Katz KS, et al. Gene: a gene-centered information resource at NCBI. Nucleic Acids Res. 2015;43(D1):D36-D42.
Pruitt KD, Brown GR, Hiatt SM, et al. RefSeq: an update on mammalian reference sequences. Nucleic Acids Res. 2014;42(D1):D756-D763.
Rosenbloom KR, Armstrong J, Barber GP, et al. The UCSC genome browser database: 2015 update. Nucleic Acids Res. 2014;43:D670-D681.
Trapnell C, Roberts A, Goff L, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012;7(3):562-578.
Liao WW, Yen MR, Ju E, Hsu FM, Lam L, Chen PY. MethGo: a comprehensive tool for analyzing whole-genome bisulfite sequencing data. Bmc Genomics. 2015;16(12):S11.
Chalmel F, Primig M. The annotation, mapping, expression and network (AMEN) suite of tools for molecular systems biology. BMC Bioinf. 2008;9:1-11.
Xie D, Chen CC, Ptaszek LM, et al. Rewirable gene regulatory networks in the preimplantation embryonic development of three mammalian species. Genome Res. 2010;20(6):804-815.
Dai M, Wang P, Boyd AD, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 2005;33(20):1-9.
Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
Bajrami E, Spiroski M. Genomic imprinting. Open Access Maced J Med Sci. 2016;4(1):181-184.
Johnson KC, Houseman EA, King JE, Von Herrmann KM, Fadul CE, Christensen BC. 5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients. Nat Commun. 2016;7:1-11.
Pennacchio LA, Bickmore W, Dean A, Nobrega MA, Bejerano G. Enhancers: five essential questions. Nat Rev Genet. 2013;14(4):288-295.
Tang SW, Liu J, Juay L, et al. Birth rates among male cancer survivors and mortality rates among their offspring: a population-based study from Sweden. BMC Cancer. 2016;16:196.
Brydøy M, Fosså SD, Klepp O, et al. Paternity following treatment for testicular cancer. J Natl Cancer Inst. 2005;97(21):1580-1588.
Huyghe E, Matsuda T, Daudin M, et al. Fertility after testicular cancer treatments: results of a large multicenter study. Cancer. 2004;100(4):732-737.
Gillette R, Son MJ, Ton L, Gore AC, Crews D. Passing experiences on to future generations: endocrine disruptors and transgenerational inheritance of epimutations in brain and sperm. Epigenetics. 2018;13(10-11):1106-1126.
Nilsson E, King SE, McBirney M, et al. Vinclozolin induced epigenetic transgenerational inheritance of pathologies and sperm epimutation biomarkers for specific diseases. PLoS One. 2018;13(8):e0202662.
Montjean D, Neyroud A, Yefimova M, Benkhalifa M, Cabry R, Ravel C. Impact of endocrine disruptors upon non-genetic inheritance. Int J Mol Sci. 2022;23:3350.
Khambata K, Raut S, Deshpande S, et al. DNA methylation defects in spermatozoa of male partners from couples experiencing recurrent pregnancy loss. Hum Reprod Oxf Engl. 2021;36(1):48-60.
Zhou Q, Xiong Y, Qu B, Bao A, Zhang Y. DNA methylation and recurrent pregnancy loss: a mysterious compass? Front Immunol. 2021;12:738962.
Carrell DT, Salas-Huetos A, Hotaling J. Increasing evidence of the role of the sperm epigenome in embryogenesis: oligoasthenoteratozoospermia, altered embryo DNA methylation, and miscarriage. Fertil Steril. 2018;110(3):401-402.
Boileau RM, Chen KX, Blelloch R. Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation. Genome Biol. 2023;24:41.
Ashokkumar D, Zhang Q, Much C, et al. MLL4 is required after implantation, whereas MLL3 becomes essential during late gestation. Dev Camb Engl. 2020;147(12): dev186999.
Bae S, Lesch BJ. H3K4me1 distribution predicts transcription state and poising at promoters. Front Cell Dev Biol. 2020;8:289.
Lee S, Lee DK, Dou Y, et al. Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proc Natl Acad Sci U S A. 2006;103(42):15392-15397.
Greither T, Behre HM, Herlyn H. Genome-wide association screening determines peripheral players in male fertility maintenance. Int J Mol Sci. 2022;24(1):524.
Kanungo S, Soares N, He M, Steiner RD. Sterol metabolism disorders and neurodevelopment-an update. Dev Disabil Res Rev. 2013;17(3):197-210.
Le F, Wang N, Wang Q, et al. Long-term disturbed expression and DNA methylation of SCAP/SREBP signaling in the mouse lung from assisted reproductive technologies. Front Genet. 2021;12:566168.
Graf A, Krebs S, Zakhartchenko V, Schwalb B, Blum H, Wolf E. Fine mapping of genome activation in bovine embryos by RNA sequencing. Proc Natl Acad Sci U S A. 2014;111(11):4139-4144.
Štiavnická M, Chaulot-Talmon A, Perrier JP, et al. Sperm DNA methylation patterns at discrete CpGs and genes involved in embryonic development are related to bull fertility. Bmc Genomics. 2022;23:379.
Heisterkamp N, Jenster G, Kioussis D, Pattengale PK, Groffen J. Human bcr-abl gene has a lethal effect on embryogenesis. Transgenic Res. 1991;1(1):45-53.
Millet S, Campbell K, Epstein DJ, Losos K, Harris E, Joyner AL. A role for Gbx2 in repression of Otx2 and positioning the mid/hindbrain organizer. Nature. 1999;401(6749):161-164.
Swaidan NT, Salloum-Asfar S, Palangi F, et al. Identification of potential transcription factors that enhance human iPSC generation. Sci Rep. 2020;10:21950.
Jönsson J, Renault KM, García-Calzón S, et al. Lifestyle intervention in pregnant women with obesity impacts cord blood DNA methylation, which associates with body composition in the offspring. Diabetes. 2021;70(4):854-866.
Peng X, Kraus MS, Wei H, et al. Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice. J Clin Invest. 2006;116(1):217-227.
Chatzizacharias NA, Kouraklis GP, Theocharis SE. The role of focal adhesion kinase in early development. Histol Histopathol. 2010;25(8):1039-1055.
Leoyklang P, Suphapeetiporn K, Srichomthong C, et al. Disorders with similar clinical phenotypes reveal underlying genetic interaction: sATB2 acts as an activator of the UPF3B gene. Hum Genet. 2013;132(12):1383-1393.
Dufner-Beattie J, Huang ZL, Geiser J, Xu W, Andrews GK. Mouse ZIP1 and ZIP3 genes together are essential for adaptation to dietary zinc deficiency during pregnancy. Genes N Y N 2000. 2006;44(5):239-251.
Baum AE, Hamshere M, Green E, et al. Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement. Mol Psychiatry. 2008;13(5):466-467.
Monk D. Germline-derived DNA methylation and early embryo epigenetic reprogramming: the selected survival of imprints. Int J Biochem Cell Biol. 2015;67:128-138.
Hammoud SS, Nix DA, Zhang H, Purwar J, Carrell DT, Cairns BR. Distinctive chromatin in human sperm packages genes for embryo development. Nature. 2009;460(7254):473-478.
Jenkins TG, Carrell DT. The sperm epigenome and potential implications for the developing embryo. Reprod Camb Engl. 2012;143(6):727-734.
Ståhl O, Boyd HA, Giwercman A, et al. Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries. J Natl Cancer Inst. 2011;103(5):398-406.
Al-Jebari Y, Rylander L, Ståhl O, Giwercman A. Risk of congenital malformations in children born before paternal cancer. JNCI Cancer Spectr. 2018;2(2):pky027.
Al-Jebari Y, Glimelius I, Berglund Nord C, et al. Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: a nationwide register study. PLoS Med. 2019;16(6):e1002816.